Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S.

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device.

Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.

Blindsight is distinct from another Neuralink project known as Telepathy, which is designed to allow patients with spinal ...

Neuralink's Blindsight isn’t just restoring vision; it’s redefining what it means to see, pushing human perception beyond ...

Elon Musk’s Neuralink announced his Blindsight project received the “Breakthrough Device” designation from the US Food and ...

The device enables visual perception by processing and transmitting neural signals, even without eyes or an optic nerve.

Elon Musk's company, Neuralink, has developed a new brain implant called "Blindsight" that could potentially restore vision ...

Neuralink has proven its electronics to brain connection device and now has FDA approval for a Blindsight device.

With Blindsight now receiving the FDA’s Breakthrough Device Designation, Neuralink looks set to push forward with technology ...

The US FDA has awarded breakthrough device status to Neuralink's Blindsight, an experimental implant designed to restore ...

Elon Musk's brain-chip company Neuralink has received the FDA’s "breakthrough device" designation for its experimental vision ...